Research ExplorerPublicationsAntikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial f...

Antikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)

Standard

Antikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events). / Meinertz, T.

In: INTERNIST, Vol. 48, No. 8, 08.2007, p. 874-875.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Meinertz, T 2007, 'Antikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)', INTERNIST, vol. 48, no. 8, pp. 874-875. https://doi.org/10.1007/s00108-007-1900-3

APA

Meinertz, T. (2007). Antikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events). INTERNIST, 48(8), 874-875. https://doi.org/10.1007/s00108-007-1900-3

Vancouver

Meinertz T. Antikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events). INTERNIST. 2007 Aug;48(8):874-875. https://doi.org/10.1007/s00108-007-1900-3

Bibtex

@article{8f68b54d28b74796a891ed2be4aae0fd,
title = "Antikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)",
keywords = "Administration, Oral, Angiotensin II Type 1 Receptor Blockers/adverse effects, Aspirin/adverse effects, Atrial Fibrillation/drug therapy, Biphenyl Compounds/adverse effects, Clopidogrel, Drug Therapy, Combination, Follow-Up Studies, Hemorrhage/chemically induced, Humans, Intracranial Embolism/prevention & control, Irbesartan, Myocardial Infarction/prevention & control, Platelet Aggregation Inhibitors/adverse effects, Randomized Controlled Trials as Topic, Tetrazoles/adverse effects, Thromboembolism/prevention & control, Ticlopidine/adverse effects",
author = "T Meinertz",
year = "2007",
month = aug,
doi = "10.1007/s00108-007-1900-3",
language = "Deutsch",
volume = "48",
pages = "874--875",
journal = "INTERNIST",
issn = "0020-9554",
publisher = "Springer",
number = "8",

}

RIS

TY - JOUR

T1 - Antikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)

AU - Meinertz, T

PY - 2007/8

Y1 - 2007/8

KW - Administration, Oral

KW - Angiotensin II Type 1 Receptor Blockers/adverse effects

KW - Aspirin/adverse effects

KW - Atrial Fibrillation/drug therapy

KW - Biphenyl Compounds/adverse effects

KW - Clopidogrel

KW - Drug Therapy, Combination

KW - Follow-Up Studies

KW - Hemorrhage/chemically induced

KW - Humans

KW - Intracranial Embolism/prevention & control

KW - Irbesartan

KW - Myocardial Infarction/prevention & control

KW - Platelet Aggregation Inhibitors/adverse effects

KW - Randomized Controlled Trials as Topic

KW - Tetrazoles/adverse effects

KW - Thromboembolism/prevention & control

KW - Ticlopidine/adverse effects

U2 - 10.1007/s00108-007-1900-3

DO - 10.1007/s00108-007-1900-3

M3 - SCORING: Zeitschriftenaufsatz

C2 - 17628764

VL - 48

SP - 874

EP - 875

JO - INTERNIST

JF - INTERNIST

SN - 0020-9554

IS - 8

ER -